Pub. Date : 2001 Aug
PMID : 11534892
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The development of beta2-agonists with long-acting properties, such as salmeterol and formoterol, has provided advantages over short-acting beta-agonists, such as prolonged bronchodilation, reduced day- and night-time symptoms and improved quality of sleep, and has reduced the requirement for short-acting beta2-agonists as relief medication. | Formoterol Fumarate | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |
| 2 | The development of beta2-agonists with long-acting properties, such as salmeterol and formoterol, has provided advantages over short-acting beta-agonists, such as prolonged bronchodilation, reduced day- and night-time symptoms and improved quality of sleep, and has reduced the requirement for short-acting beta2-agonists as relief medication. | Formoterol Fumarate | potassium calcium-activated channel subfamily M regulatory beta subunit 2 | Homo sapiens |